The EUA will enable wider use of remdesivir for treating hospitalised patients with severe Covid-19 disease, enabling access to the medication at more hospitals across the US, said
“The FDA’s final approval marks an important milestone for Banner and for patients living with relapsing-remitting multiple sclerosis,” said Franck Rousseau, M.D., Chief Executive Officer of Banner. “We
Until now, only 20% of women with ovarian cancer, those with a BRCA mutation (BRCAm), were eligible to be treated with a PARP inhibitor as monotherapy in the
We believe our product DEXTENZA for AC has potential as a hands-free therapy administered in the office setting as a bioresorbable, intracanalicular insert, designed to release the corticosteroid
The approval is for the use of the KEYTRUDA dosage in both monotherapy and combination therapy. According to Merck, the FDA granted the accelerated approval of the new
Merck has also entered into an agreement with the Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response
The company’s AAVSmartLibrary and associated technology are said to be used for developing AAV capsids for enhanced tissue tropism, manufacturability, and pre-existing immunity. The collaboration will make use
The data will be presented as a virtual poster at the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting I. This ongoing study is an open
Lynparza delivered the result in the PROfound trial, which is being carried out in men with metastatic castration-resistant prostate cancer (mCRPC) who have a homologous recombination repair gene
This represents the first financing round to be completed since the company’s founding in June 2014, when Affinivax received an initial seed and Series A equity investment from
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.